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Abstract: To avoid spreading the Corona Virus Disease 2019 (COVID-19), health authorities have
forced people to reorganize their working and private lives and to avoid open and public spaces
as much as possible. This has also been the case for women both during pregnancy and after
delivery. Here, we investigated the associations between subjective beliefs in risk of infections
and health anxiety, depression, stress, and other perinatal dimensions. To this end, we assessed
103 women (mean age: 28.57 years) during pregnancy and after delivery. They completed a series
of questionnaires covering sociodemographic information, perinatal information, health anxiety,
post-partum depression, and stress. Sixty-six participants (64.1%) were in the pre-partum stage,
and 37 (35.9%) were post-partum. Health anxiety was unrelated to depression or stress. Knowing
and being close to infected people was associated with higher health anxiety. Strict following of
the safety recommendations was associated with greater health anxiety, depression, and stress.
Postponing or cancelling routine medical check appointments was observed among participants
with high health anxiety scores. Higher illness severity, overall health anxiety scores, and lower
stress scores predicted those participants who postponed or cancelled their routine medical check
appointments. Post-partum stage and a larger number of children were associated with higher stress
scores, but not with depression or stress. The results are of practical and clinical importance; it
appears that health anxiety, which is to say fear of getting infected with COVID-19 during pregnancy
or at the post-partum stage, was associated with postponing or cancelling routine medical check
appointments, but not with stress or depression.
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1. Introduction
In Iran, the emergence of the Coronavirus Disease 2019 (COVID-19) and the associated epidemic
risk forced health authorities to protect their citizens from both getting infected and spreading the virus
to others [1,2]. To this end, restrictions were placed on going into open and crowded spaces; borders,
educational institutions (kindergartens, schools, universities), cultural and sports areas, and religious
and sacred places were (temporarily) closed. As of the end of April 2020, of 330,137 tested patients,
80,868 had been infected with COVID-19. Of these, 55,987 had recovered, 3513 remained critically ill
and 5031 people had died [3]. Announcement of the lockdown also appears to have caused panic and
anxiety [1,2].
Typically, epidemic danger is associated with unpredictability and uncertainty [4]. In this particular
case, unpredictability and uncertainty are associated with anxiety about getting infected by COVID-19.
Among 1789 Iranian adults responding to an online survey on this topic, 68% reported moderate
to severe anxiety about getting infected. Women and participants with a modest health status had
1.91- to 3.46-fold increased odds of recording moderate to high anxiety scores [5]. Higher scores
for self-reported levels of stress, anxiety, and depression have been reported not only in the general
population [6] but also within and between different countries [7].
Inspecting the evidence in more detail reveals that levels of anxiety were higher among women
than men, among people following COVID-19 news, among adults aged 20 to 40 years, and among
individuals with at least one family member, relative, or friend who had contracted the disease [8].
Compared to those who survived an infection, individuals who later died from the disease had higher
self-reported anxiety and depression scores and higher cortisol concentrations. Higher anxiety scores
and higher serum cortisol levels were associated [9].
As regards women in the perinatal stage of a pregnancy, there is an argument that morning sickness
emerged during evolution to protect the fetus and embryo from toxins [10]. It would therefore seem that,
compared to men and women who are not pregnant or have not recently given birth, women during
the perinatal period need greater protection against physiological and psychological harm, as well
as increased health care and attention. This increased attention is required for the unborn or newly
born child as well as for the benefit of the women’s physical and psychological state. Psychological
distress during the perinatal period can be associated with psychophysiological changes increasing
the risk of perinatal/postnatal symptoms of depression [11]. Relatedly, among pregnant women,
the prevalence of a clinical anxiety disorder was found in one study to be 15.2%, while the prevalence
of a generalized anxiety disorder was 4.1% [12]. Importantly, higher anxiety scores during pregnancy
and the perinatal period might negatively influence outcomes for the child [12,13]. Results from a
meta-analysis indicate that psychological, social, and physiological factors may increase the risk of both
new onset anxiety and a worsening of anxiety during the perinatal period [14]. Results from systematic
reviews have also shown the dimensions of anxiety, depression, and stress during the perinatal period
to be interrelated [15,16]. From an evolutionary point of view, anxiety during the perinatal period
might help pregnant women avoid exposure to toxins and risky behavior [17–19]. This mechanism
may help to explain why during the COVID-19 pandemic pregnant women have recorded higher
scores for anxiety, stress, and depression [20–24], and have displayed avoidance behavior with respect
to hospital visits [21,25], gynecologic triage and ultra-sound units [26], and more safety behaviors such
as opting for epidural analgesia [26], cesarean section, bottle feeding, and postnatal rest at home [25].
The cognitive-emotional concept of health anxiety is similar to anxiety, but closer to a subjective
uncertainty about staying or remaining healthy. Health anxiety is understood as a dimensional
construct ranging from “not observable” to “extremely severe” [27,28]. The most intensive form of
health anxiety is hypochondriasis or somatic symptom disorder and illness anxiety disorder following
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the DSM-5 [29]. In the present study, we decided to assess health anxiety and not state or trait anxiety;
unlike state or trait anxiety, health anxiety concerns the cognitive-emotional belief that one’s health
is in danger. As such, health anxiety is considered a health belief model. Studies on health belief
models [30–32] have shown that subjective beliefs impact on a person’s susceptibility to illnesses. Thus,
healthy belief models, and in this case health anxiety, influence the degree to which a woman in the
perinatal stage believes she is more or less susceptible to infection by the COVID-19 disease.
Given this background, in the present study we combined psychological findings related to the
COVID-19 pandemic with the particular status of females during the perinatal period. More specifically,
we investigated whether health anxiety, stress or depression led to postponement or even cancellation
of routine medical health care appointments, given that such forms of avoidance behavior might
increase the risks of additional health issues both for the (future) mothers and for their children.
The following three hypotheses and three research questions were formulated. First, following
others [6,15,16], we expected that self-rated dimensions of health anxiety, depression, and stress would
be related. Second, following Moghanibashi-Mansourieh [8], we hypothesized that being in touch
with an intimate (family member, close friend, neighbor) testing positive for COVID-19 would increase
the odds of higher health anxiety scores. Third, following both the evolutionary hypothesis of health
anxiety as a protective strategy to avoid contact with toxins and to avoid risky behavior [17–19] and
recent findings indicating avoidance behavior by pregnant women during the pandemic [21,25,26],
we anticipated that higher health anxiety scores would be associated with higher odds of postponing
or cancelling routine health care appointments. We treated as exploratory the question of which
dimensions (health anxiety, depression, stress, age) would predict those participants postponing or
cancelling their routine medical health care appointments. The second exploratory research question
concerned the relation of health anxiety, stress and depression to sociodemographic dimensions such
as age, number of pregnancies (including prematurely terminated pregnancies), number of children,
employment status, and level of education. The third exploratory question was whether participants
recorded different scores on health anxiety, depression, and stress before versus after delivery.
To test the hypotheses and to address the research questions, women in the perinatal period
completed a series of questionnaires. We believe that this study has the potential to identify those




Women in the perinatal period and registered as patients with the Department of Gynecology and
Midwifery of the Arak University of Medical Sciences (ARAKMU; Arak, Iran) were approached to
participate in the present cross-sectional study on the associations between symptoms of depression,
stress, and anxiety during the Covid-19 lockdown. All eligible participants were informed about the
aims of the study and the secure and anonymous data handling. Thereafter, participants signed a
written informed consent. They then completed a booklet of questionnaires covering sociodemographic
information, information regarding pregnancy, delivery and the post-partum stage, health anxiety
(Health Anxiety Inventory; see the description of the questionnaires below), post-partum depression
(Edinburgh Postnatal Depression Scale; EPDS; see below), perceived stress (Perceived Stress Scale;
see below), and specific COVID-19-related questions (see below).
The ethical committee of the Arak University of Medical Sciences (ARAKMU; Arak, Iran) approved
the study (code: IR.ARAKMU.REC.1399.016), which was performed in accordance with the seventh
and current version [33] of the Declaration of Helsinki.
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2.2. Participants
Of 120 women approached, 103 (85.84%) agreed to participate. Inclusion criteria were: (1) At least
18 years old; (2) either in a prenatal stage or postnatal stage no longer than six weeks after delivery;
(3) Willing and able to comply with the study requirements. (4) Signed written informed consent.
Exclusion criteria: (1) Current or past (six months before pregnancy) severe psychiatric issues such as
major depressive disorders, bipolar disorders, schizophrenia spectrum disorder, severe sleep disorders,
substance use disorder; to this end an experienced psychiatrist or clinical psychologist performed
a brief psychiatric interview based on the DSM-5 [34]. (2) Current severe physiological issues such
as diabetes or allergies, including surgery with narcosis, which by definition temporarily alters
psychophysiological status.
Being infected with COVID-19 was not an exclusion criterion though at the time of assessment




Participants reported their age (in years), highest educational level (compulsory school; diploma;
higher diploma; higher educational training), employment status (employed: yes vs. no), number of
children, and number of pregnancies.
2.3.2. Health Anxiety
To assess health anxiety, participants completed the Persian version [35] of the Health Anxiety
Inventory [27]. The questionnaire consists of 18 questions focusing on anxiety about one own’s
health, ranging from no fear of health at all to hypochondriasis (DSM-IV; [36]) or somatic symptom
disorder and illness anxiety disorder (DSM-5; [29]). Hypochondriasis is understood as the clinical
and dysfunctional belief that one is suffering from or going to be affected by a severe and dangerous
disease. Typical items are: 1. (a) “I do not worry about my health”; (b) “I occasionally worry about
my health”; (c) “I spend much of my time worrying about my health”; (d) “I spend most of my time
worrying about my health”; 2. (a) ”I notice aches/pains less than most other people (of my age)”;
(b) “I notice aches/pains as much as most other people (of my age)”; (c) “I notice aches/pains more than
most other people (of my age)”; (d) “I am aware of aches/pains in my body all the time”. 3. (a) “As a
rule, I am not aware of bodily sensations or changes”; (b) “Sometimes I am aware of bodily sensations
or changes”; (c) “I am often aware of bodily sensations or changes”; (d) “I am constantly aware of
bodily sensations or changes”. Items are aggregated to the following dimensions: Illness severity,
illness likelihood, body vigilance, and the total score. Higher sum scores reflect a more pronounced
severity of health anxiety.
2.3.3. Behavior Related to the COVID-19 Pandemic
Three self-administered items focused on COVID-19-related behavior:
1. “Do you live with a person (family member; relative; colleague at work) currently infected with
COVID-19?” Response alternatives, treated as a Likert scale, were the following: No (=1); yes,
but not no direct contact (=2); yes, and with direct contact (=3).
2. “How necessary is it to adhere to the hygiene and social distancing recommendations?” Response
alternatives, again treated as a Likert scale, were: Not necessary (=1); it is necessary, but I
do not strictly follow the rules (=2); it is necessary, and I do follow the rules (=3); this is
absolutely necessary; when I see that other people do not follow the rules, I get worried and feel
uncomfortable (=4)
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3. “Have you postponed or cancelled routine medical health care appointments for your and/or
your child?” Response alternatives were: No (=1); yes (=2).
2.3.4. Self-Ratings of Symptoms of Depression
Participants completed the Persian version [37] of the Edinburgh postnatal depression scale
EPDS [38], which consists of ten items. Anchor points for each item are 0 and 3. Higher total scores reflect
more marked symptoms of postnatal depression. The maximum score is 30. (Cronbach’s alpha = 0.83).
2.3.5. Perceived Stress
Participants completed the 14-items Perceived Stress Scale (PSS [39]), a self-report measure
designed to assess whether and to what extent situations in a person’s life are considered as stressful,
unpredictable, uncontrollable, and overloading. The Persian version has been psychometrically
validated [40–42]. Typical items are: “In the last month how often have you felt that you were unable to
control the important things in your life”, or “ . . . how often have you been upset because of something
that happened unexpectedly?”, or “ . . . how often have you felt confident about your ability to handle
your personal problems?”. Answers are given on 5-point rating scales ranging from 0 (=never) to 4
(very often). Some questions are positively worded and some are reverse coded. Higher sum scores
reflect a higher perceived stress (Cronbach’s alpha = 0.83).
2.4. Statistical Analysis
With a series of Pearson’s correlations associations between participants’ age, health anxiety,
depression, and stress were calculated. Three multivariate ANOVAs were performed with the three
COVID-19 related questions as independent factors, and health anxiety, depression, and stress as
dependent variables. For post-hoc analyses, Bonferroni-Holm corrections for p-values were used.
A binary logistic regression was performed to predict postponing/cancelling medical routine health
care appointments (yes vs. no) as a function of health anxiety, depression, stress, and age. A series
of t-tests and X2-tests was performed to investigate differences in health anxiety, depression, stress,
and COVID-19-related issues between participants before and after delivery. The nominal level
of significance was set at alpha <0.05. Statistical computations were performed with SPSS® 26.0
(IBM Corporation, Armonk, NY, USA) for Apple Mac®.
3. Results
3.1. General Overview
A total of 103 women (mean age: 28.57 years; SD = 6.85) took part in the study. Of these, 66 (64.1%)
were assessed during pregnancy (second and third trimester), and 37 (35.9%) were assessed after
delivery. Table 1 provides the descriptive and inferential statistical indices of sociodemographic
information, scores of health anxiety, depression, and stress, and COVID-19-related issues, both for
the entire study sample, and separately for participants before and after delivery. Statistical indices
reported in tables are not repeated in the text.
Compared to pregnant participants, participants after delivery reported significantly higher stress
and a greater number of children. For all other dimensions (age, number of pregnancies, health anxiety,
depression, COVID-19-related questions, education and employment status), no descriptive or statistical
differences were observed.
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Table 1. Descriptive and inferential statistical overview of sociodemographic, pregnancy-related, and psychological dimensions; the entire sample (n = 103) and
separately for participants before (n = 66) and after delivery (n = 37).
Samples Statistics
Total Sample Before Delivery After Delivery F (1, 101) ηp2
n 103 66 37
M (SD) M (SD) M (SD)
Age 28.57 (6.85) 28.97 (7.45) 27.86 (5.62) 0.62 0.006 (T)
Number of pregnancies 2.20 (1.10) 2.35 (1.12) 1.95 (1.03) 3.26 0.031 (S)
Number of children 1.41 (0.99) 1.23 (0.99) 1.73 (0.93) 6.37 * 0.060 (M)
Samples Statistics
Total Sample Before Delivery After Delivery F (1, 101) ηp2
Gestational age (weeks) 27.20 (5.77) -
Time lapse after delivery (weeks) - 4.82 (0.67)
Health anxiety
Illness likelihood 24.63 (5.58) 24.85 (5.23) 24.24 (6.23) 0.28 0.003 (T)
Illness severity 5.27 (3.50 5.33 (3.21) 5.16 (4.00 0.06 0.001 (T)
Body vigilance 9.20 (2.34) 9.21 (2.25) 9.19 (2.52) 0.02 0.000 (T)
Total score 29.31 (9.60) 39.70 (8.57) 38.62 (11.24) 0.30 0.010 (T)
Edinburgh Postnatal Depression 12.77 (3.66) 12.50 (4.04) 13.24 (2.84) 1.00 0.010 (T)
Perceived stress 22.23 (7.30) 20.29 (7.46) 25.70 (5.58) 14.81 *** 0.128 (M)
n (%) n (%) n (%)
Q1; Close person with COVID-19? (no/yes + no contact;
yes + contact 61/40/2 39/26/1 22/14/1 X
2 (n = 103; df = 2) = 0.19
Q2; necessary to adhere to the rules? (yes + I adhere
sometimes; yes + always; yes + worries) 10/59/34 8/40/18 2/19/16 X
2 (n = 103; df = 2) = 3.29
Q3; postponing/cancelling appointments (yes/no) 57/46 39/27 18/19 X2 (n = 103; df = 2) = 1.05
n (%) n (%) n (%)
Education (compulsory school/diploma/higher education) 33/47/23 25/31/10 8/16/13 X2 (n = 103; df = 2) = 6.36
Employment (yes, no) 26/77 14/52 12/25 X2 (n = 103; df = 1) = 1.58
Notes: * = p < 0.05; *** = p < 0.001. T = trivial effect size; S = small effect size; M = medium effect size.
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3.2. Associations between Age, the Number of Children, Health Anxiety, Depression, and Stress
Table 2 provides the correlations for age, number of children, health anxiety, depression, and stress.
Table 2. Overview of Pearson’s correlation coefficients between age, number of children, health anxiety,
depression, and stress.
Dimensions
Age Number Children Health Anxiety Depression Stress
Age - 0.44 *** 0.16 0.04 0.15
Number of children - 0.15 −0.00 0.27 **
Health anxiety inventory - 0.07 −0.04
Edinburgh Depression Scale - 0.14
Perceived stress scale -
Notes: ** = p < 0.01; *** = p < 0.001.
Correlations between age, health anxiety, depression, and stress were trivial to low. A greater
number of children was associated with higher stress and with older age.
3.3. Concerns about COVID-19 and Symptoms of Health Anxiety, Depression, and Stress
Table 3 provides the descriptive and inferential statistical indices for health anxiety, depression,
and stress as dependent variables and the three COVID-19-related questions as independent factors.
Participants living with or being in contact with a person with COVID-19 had significantly higher
health anxiety scores. No differences were found for depression or stress.
Participants adhering strictly to the rules and feeling worried and uncomfortable recorded
significantly higher health anxiety and depression scores. No differences were found for stress.
Participants postponing/cancelling routine medical care appointments had significantly higher
health anxiety and depression scores. No differences were found for stress. Figure 1 displays the health
anxiety scores of participants who respectively did and did not postpone or cancel routine medical
care appointments.
Figure 1. Health anxiety scores of participants who did (n = 57) and who did not (n = 46) postpone or
cancel routine medical appointments. Notes: *** = p < 0.001; d = Cohen’s d: Large effect size.
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Table 3. Health anxiety, depression, and stress, depending from COVID-19-related questions.
Dimensions
Health Anxiety Statistics Depression Statistics Stress Statistics
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Notes: * = p < 0.05; *** = p < 0.001; T = trivial effect size; S = small effect size; M = moderate effect size; L = large effect size.
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3.4. Postponing/Cancelling Routine Medical Care Appointments
To predict who did or did not postpone/cancel routine medical care appointments, a binary
logistic regression was performed (see Table 4 for details). The accuracy of the model in assigning
participants to the respective dichotomous groups (postponing/cancelling: yes vs. no) was 92.2%
(54 out of 57 participants correctly assigned as “yes”; 41 out of 46 correctly assigned as “no”). Predictors
explained 85% of the variance of the outcome variable (Nagelkerke R2: 0.85). Higher illness severity
scores and higher total health anxiety, but lower stress predicted which participants postponed/cancelled
routine medical care appointments. Illness likelihood, body vigilance, and depression were excluded
from the equation as their indices did not reach statistical significance.
Table 4. Binary logistic regression analysis with postponed or cancelled routine health care appointments
(yes vs. no) as dependent variable, and illness severity, health anxiety and stress as predictors.
Dimension Variables Coefficient Standard Error Wald p Nagelkerke R2
Postponing/cancelling
appointments (yes vs. no)
Constant −18.97 5.64 11.31 0.002 0.85
Illness severity 0.507 0.206 6.05 0.014
Health anxiety; total 0.496 0.147 11.30 0.001
Stress −0.161 0.068 5.66 0.017
Excluded variables Illness likelihood, body vigilance, depression (all Wald’s < 1.8, all p’s > 0.10.
4. Discussion
The key results of the present study were that among women in a perinatal stage health anxiety
was unrelated to depression or stress. However, health anxiety was related to being close to people
infected with COVID-19, and to worrying about getting infected with COVID-19. Furthermore,
higher illness severity and overall health anxiety, and lower stress scores predicted those participants
postponing or cancelling routine medical health care appointments. Next, women in the postpartum
stage and having more children reported higher stress. The present results add to the current literature
in the following important ways. First, health anxiety was not related to depression or stress but was
related to the risk of getting infected by intimate associates with COVID-19. Second, on a behavioral
level, health anxiety was related to postponing or cancelling routine medical health care appointments
(both for the mothers and their children); avoidance behavior of this kind carries the risk that health
issues will be missed or overlooked.
Three hypotheses and three exploratory research questions were formulated, and each of these is
considered in turn.
Our first hypothesis was that scores for health anxiety, depression, and stress would be associated,
but this was not supported; the correlations between health anxiety, depression, and stress were
trivial to low. Higher stress was associated with a greater number of children which in turn
was related to participants’ older age. Given this, the present results to not confirm previous
findings [6,15,16,20–22,24,25,43].
Our second hypothesis was that women in the perinatal stage and living close to people infected
with COVID-19 would record higher health anxiety scores, and this was supported. In this respect the
present results are consistent with findings reported in a previous study [8]. However, we believe that
the present data do add to the current literature in an important way: Health anxiety was unrelated to
depression or stress, but to the subjective sense of avoiding possible exposure to the virus.
The evidence available to us from this study is unable to illuminate the cognitive-emotional
mechanisms that might account for the results relating to these two hypotheses. Given this, we advance
the following possibilities. First, while previous studies have assessed (state or trait) anxiety, we assessed
health anxiety, which is a person’s (dysfunctional) cognitive-emotional health belief model. As such,
a health belief model will not necessarily be related to objective stressors or to symptoms of depression
but to the dysfunctional belief that one’s body might become severely ill, irrespective of any objective
danger. Second, and relatedly, even if a woman in the perinatal stage is living close to a person
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infected by COVID-19, precautions such as social distancing and scrupulous respect of hygiene rules
could objectively and securely have protected her from getting infected. However, it is characteristic
of health anxiety and health beliefs models that they do not take objective circumstances into
consideration [30–32].
Our third hypothesis was that health anxiety would be related to postponing or cancelling routine
medical health care appointments and this was supported. Given that no research question stated in
this specific form has previously been addressed, we refer to the concepts of evolutionary psychology
and evolutionary psychiatry. Health anxiety is considered a protective strategy to avoid contact with
toxins and to avoid risky behavior [17–19]. Thus, from an evolutionary point of view, avoidance of
danger makes sense. However, and in the present specific context, avoidance in terms of postponing or
cancelling routine medical health care appointments can put mothers’ and children’s health at risk in
the longer term, given that the key aim of such routine medical health care appointments is to detect and
address potential health issues. As such, women in the perinatal stage with high health anxiety appear
to create a conflict between short-term benefits (harm avoidance) and long-term costs (preventing
and dealing with health issues). The following observations give some support to the mechanisms
described above. During the COVID-19 pandemic, 25.8% of 2740 pregnant Canadian women stopped
their in-person visits, and the main reason given was concern about getting infected [21]. During the
COVID-19 pandemic, pregnant women in Wuhan (China) often refused to go to any hospital, and 12.7%
more women than planned refused vaginal delivery and opted for cesarean section [25]. Visits to
obstetric triage, gynecological triage, and ultra-sound units decreased by one third in an Israeli hospital;
additionally, more epidural analgesia was requested and nulliparous asked more often for operative
vaginal deliveries [26]. A higher rate of pregnant women in Sardinia asked for voluntary termination
of pregnancy; others asked for invasive prenatal screening [43].
The first exploratory research question concerned the degree to which health anxiety, depression,
stress, and age might independently or in combination predict postponement or cancellation of routine
medical health care appointments. It turned out that higher health anxiety traits and lower stress
predicted those participants reporting these kinds of avoidance behavior, thus confirming what has
previously been observed and discussed. However, it was unexpected that lower stress was associated
with higher avoidance given that stress and health anxiety were unrelated. The quality of the data
does not allow a deeper understanding of this finding. However, we believe that various confounding
factors were involved. Higher stress was associated with older age and with a greater number of
children; complementary to this it is possible that younger participants with fewer children were
more prone to avoid routine medical health care appointments. Thus, though it is admittedly highly
speculatively, it is possible that the older participants with more children and more experience to draw
upon made more informed decisions about routine medical health care appointments.
Our second exploratory research question addressed the possibility that sociodemographic and
perinatal dimensions are related to dimensions of health anxiety, depression, and stress, and the answer
was no.
The third research study question concerned the possibility that participants before and after
delivery respectively would have different levels of health anxiety, depression stress, and other perinatal
and COVID-19-related issues. As shown in Table 1, participants after delivery recorded higher stress
scores. In our opinion this is unsurprising given that caring for an infant is likely to involve a degree
of stress.
Despite the novelty of the results, the following limitations warrant against their overgeneralization.
First, participants were recruited from only one study center and only participants willing and able to
comply with the study conditions took part in the study; it follows that sample-related biases cannot be
fully ruled out. Second, the cross-sectional character of the study design precludes conclusions about
causal relationships between the variables. Third, a follow-up design would have allowed us to assess,
whether postponing or cancelling routine medical health care appointments had consequences for
participants’ or their children’s health. Likewise, fourth, it would have been interesting to explore if
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such avoidance behavior was associated with a lower risk of getting infected with COVID-19. Similarly,
fifth, if any participants had become infected by COVID-19, it would have been interesting to calculate
whether this outcome could have been predicted from the present data. Sixth, it is conceivable that
unassessed and latent variables such as abortion/miscarriage biased two or more dimensions in the
same or opposite directions. Seventh, the sample size was small, though we focused on effect size
calculations which are unrelated to sample size. Eighth, apart from avoidance behavior, we did not ask
if participants used alternative strategies such as online consultation [21,25,44] or phone visits [21].
Furthermore, it turns out that during the COVID-19 pandemic pregnant women with higher physical
activity indices have also reported lower anxiety and depression scores [24]. As such, in addition to
social support, regular physical activity should be taken into consideration in efforts to improve the
physical and mental health of perinatal stage women [24,45].
5. Conclusions
Among a sample of women in the perinatal stage and assessed during the COVID-19 pandemic,
health anxiety was unrelated to symptoms of depression and stress. Rather, health anxiety was
related to proximity to closer others suffering from COVID-19. Importantly, higher health anxiety was
related to postponing or cancelling routine medical health care appointments for the participant or her
child. Consequently, higher health anxiety could be associated with a greater risk of not detecting or
prevent potential health problems. We speculate that women in the perinatal stage with high health
anxiety appeared to have a conflict between short-term benefits (harm avoidance) and longer-term
disadvantages (preventing and detecting health issues).
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